Eton Pharmaceuticals, Inc. Contracts & Agreements

59 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement dated December 31, 2024 between Teva Pharmaceuticals USA, Inc. and the Registrant (portions of the Exhibit have been redacted)
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Purchase Agreement
Purchase Agreements
Eton Pharmaceuticals, Inc.
2024
Second Amendment to Warrant Agreement by and among the Company and SWK Funding LLC dated as of September 30, 2024
Warrant Agreements
Eton Pharmaceuticals, Inc.
2024
Fifth Amendment to Credit Agreement by and among the Company and SWK Funding LLC dated as of September 30, 2024
Credit Agreements
Eton Pharmaceuticals, Inc.
2024
Offer Letter Agreement by and between the Registrant and James Gruber, dated as of March 25, 2022
Eton Pharmaceuticals, Inc.
2023
Asset Purchase Agreement by and among the Company and Dr. Reddys Laboratories S.A., dated as of June 24, 2022
Purchase Agreements
Eton Pharmaceuticals, Inc.
2022
Credit Agreement by and among the Company, the Lenders party thereto, and SWK Funding LLC , as administrative agent dated as of November 13, 2019 and conformed through Third...
Credit Agreements
Eton Pharmaceuticals, Inc.
2022
Underwriting Agreement, dated as of April 8, 2021, by and among Eton Pharmaceuticals, Inc., Harrow Health, Inc. and National Securities Corporation
Underwriting Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Description of Securities of the Registrant
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2021
2018 Equity Incentive Plan (as amended December 2020
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2021
Underwriting Agreement between the Company and National Securities Corporation dated October 14, 2020
Underwriting Agreements
Eton Pharmaceuticals, Inc.
2020
Promissory Note between Eton Pharmaceuticals, Inc. and Bank of America, NA
Note Agreements
Eton Pharmaceuticals, Inc.
2020
Securities Purchase Agreement dated March 26, 2020 by and between the Company and Opaleye L.P
Purchase Agreements
Eton Pharmaceuticals, Inc.
2020
Purchase Agreement dated March 26, 2020 by and among the Company and Certain Investors
Purchase Agreements
Eton Pharmaceuticals, Inc.
2020
First Amendment to Credit Agreement dated as of March 26, 2020 by and between the Company and SWK Funding LLC, as Agent
Credit Agreements
Eton Pharmaceuticals, Inc.
2020
Warrant dated November 13, 2019 issued to SWK Holdings LLC
Warrant Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2020
Credit Agreement dated as of November 13, 2019, by and among the Company and SWK Funding LLC
Credit Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2020
Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc., effective as of July 30, 2019 (but executed as of June 12,...
Note Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Agreement between Eton Pharmaceuticals, Inc. and Sintetica SA, dated as of February 8, 2019
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Agreement between Eton Pharmaceuticals, Inc. and Eyemax LLC, dated as of February 18, 2019
Eton Pharmaceuticals, Inc.
Pharmaceuticals
DE
2019
Agreement between Eton Pharmaceuticals, Inc. and Bausch Health Ireland Limited (BIRL), dated as of February 18, 2019
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Agreement between Eton Pharmaceuticals, Inc. and Liqmeds Worldwide Limited, dated as of January 23, 2019
Eton Pharmaceuticals, Inc.
2019
Agreement between Eton Pharmaceuticals, Inc. and Sintetica SA, dated as of February 8, 2019
Eton Pharmaceuticals, Inc.
2019
Agreement between Eton Pharmaceuticals, Inc. and Harrow Health Inc., dated as of May 6, 2019
Eton Pharmaceuticals, Inc.
2019
Form of Underwriters Warrant
Warrant Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Form of Underwriting Agreement
Underwriting Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Specimen Certificate representing shares of common stock of Registrant
Stock Agreements
Eton Pharmaceuticals, Inc.
2018
Form of Underwriting Agreement
Underwriting Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Specimen Certificate representing shares of common stock of Registrant
Stock Agreements
Eton Pharmaceuticals, Inc.
2018
Form of Underwriters Warrant
Warrant Agreements
Eton Pharmaceuticals, Inc.
2018
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant
Sales Agreements
Eton Pharmaceuticals, Inc.
2018
2018 Employee Stock Purchase Plan
Stock Agreements
Eton Pharmaceuticals, Inc.
2018
Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017 between Amphastar Pharmaceuticals, Inc. and the Registrant
Development Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Exclusive License and Supply Agreement (ET-103) dated August 3, 2018 between the Registrant, Liqmeds Worldwide Limited and LM Manufacturing, Ltd
License Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
2017 Equity Incentive Plan
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
2018
2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2018
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant
Sales Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Amendment No. 1 dated August 29, 2018 to Sales/Marketing Agreement (DS-300) dated November 17, 2017 between AL Pharma, Inc. and the Registrant
Eton Pharmaceuticals, Inc.
2018
Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017
Development Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Exclusive License and Supply Agreement (ET-103) dated August 3, 2018 between the Registrant, Liqmeds Worldwide Limited and LM Manufacturing, Ltd
License Agreements
Eton Pharmaceuticals, Inc.
2018
2017 Equity Incentive Plan
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
2018
2018 Equity Incentive Plan
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2018
2018 Employee Stock Purchase Plan
Stock Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
2018
Development, Supply and Commercialization Agreement (CT-100) dated November 7, 2017
Development Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Exclusive License and Supply Agreement (ET-103) dated August 3, 2018 between the Registrant, Liqmeds Worldwide Limited and LM Manufacturing, Ltd
License Agreements
Eton Pharmaceuticals, Inc.
2018
Offer Letter Agreement by and between the Registrant and W. Wilson Troutman, dated as of June 27, 2017
Eton Pharmaceuticals, Inc.
Pharmaceuticals
IL
2018
Offer Letter Agreement by and between the Registrant and Sean E. Brynjelsen, dated as of May 17, 2017
Eton Pharmaceuticals, Inc.
2018
Consulting Agreement by and between the Registrant and Mark L. Baum, dated as of May 1, 2017
Consulting Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Eton Pharmaceuticals, Inc. 2017 Stock Incentive Plan
Bonus & Incentive Agreements
Eton Pharmaceuticals, Inc.
2018
Sales/Marketing Agreement (DS-300) dated November 17, 2017 by and among AL Pharma, Inc., SCS National, LLC, Dry Creek Project, LLC and the Registrant
Eton Pharmaceuticals, Inc.
Pharmaceuticals
OK
2018
Exclusive Sales and Marketing Agreement (EM-100) dated August 11, 2017 between Eyemax, LLC and the Registrant
Sales Agreements
Eton Pharmaceuticals, Inc.
2018
Exclusive Development and Supply Agreement (DS-100) dated July 9, 2017 between Andersen Pharma, LLC and the Registrant
Development Agreements
Eton Pharmaceuticals, Inc.
2018
Asset Purchase Agreement (DS-200) dated June 23, 2017 between Selenix, LLC and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement (CT-200) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
CA
2018
Asset Purchase and License Agreement (CT-100) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant
Purchase Agreements
Eton Pharmaceuticals, Inc.
2018
Registration Rights Agreement dated June 19, 2017 by and among the Registrant and certain of its stockholders
Registration Rights Agreements
Eton Pharmaceuticals, Inc.
2018
Securities Purchase Agreement dated June 19, 2017 by and among the Registrant and the Buyers named therein
Purchase Agreements
Eton Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Warrant dated June 26, 2017 issued to National Securities Corporation
Warrant Agreements
Eton Pharmaceuticals, Inc.
2018
Warrant dated May 4, 2017 issued to Liquid Patent Advisors, LLC
Warrant Agreements
Eton Pharmaceuticals, Inc.
2018